Inhibitor Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Inhibitor Therapeutics, Inc. (INTI) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $6.43 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-26
- Inhibitor Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $6.43K, a 15.08% increase from fiscal 2024.
- Inhibitor Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $5.58K, a 87.62% decline from fiscal 2023.
- Inhibitor Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $45.10K.
- Inhibitor Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was -$70.95K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|
| 2025-12-31 | $6.43K 10-K · filed 2026-03-26 |
| 2024-12-31 | $5.58K 10-K · filed 2026-03-26 |
| 2023-12-31 | $45.10K 10-K · filed 2025-03-28 |
| 2022-12-31 | -$70.95K 10-K · filed 2024-03-29 |
| 2021-12-31 | -$905.00 10-K · filed 2023-03-31 |
| 2020-12-31 | -$13.67K 10-K · filed 2022-03-30 |
| 2019-12-31 | $40.09K 10-K · filed 2021-03-26 |
| 2018-12-31 | -$24.36K 10-K · filed 2020-03-30 |
| 2017-12-31 | -$369.40K 10-K · filed 2019-03-07 |
| 2016-12-31 | $74.36K 10-K · filed 2018-02-16 |
| 2015-12-31 | $20.95K 10-K · filed 2017-02-17 |
| 2014-12-31 | $80.90K 10-K · filed 2016-02-01 |